Videos

Optimizing Overall Health During CLL Management

June 19th 2024, 7:30pm

Yuliya Linhares, MD, discusses how healthy lifestyle choices, such as diet and exercise, can play a valuable role in optimizing CLL treatment outcomes.

Treatment Option for Polycythemia Vera

June 17th 2024, 4:24pm

Don’t Delay Bringing Up CML Concerns, a Doctor Says

June 15th 2024, 2:00pm

To ensure best outcomes, patients with chronic myeloid leukemia should maintain frequent communication with their care teams — even between appointments.

Most Patients With CML Can Continue Their Normal Lifestyle During Treatment

June 14th 2024, 10:00pm

Most — though not all — side effects from chronic myeloid leukemia treatment improve over time, an expert said.

Organizations Can Help Patients with CML Face the ‘Long Treatment Journey’

June 14th 2024, 9:00pm

A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.

Putting Quality of Life into Perspective During CML Treatment

June 13th 2024, 9:00pm

Patients with chronic myeloid leukemia should be upfront with their care team about how treatment side effects are affecting their daily functioning.

Understanding the Disease, Treatments Help Patients Navigate a CML Diagnosis

June 13th 2024, 1:00pm

Initial discussions about treatment, side effects and study results can help patients navigate through all aspects of a chronic myeloid leukemia diagnosis.

3 Questions to Ask Doctors After a CML Diagnosis

June 12th 2024, 8:00pm

An advocate discusses vital patient-provider conversations to promote the best care for individuals with chronic myeloid leukemia.

Shared Decision-Making and Supportive Care in the CLL Treatment Journey

June 12th 2024, 2:17pm

Clinical insights on shared decision-making practices and the importance of supportive care when treating patients with chronic lymphocytic leukemia.

Treatment Decisions in R/R CLL

June 12th 2024, 2:15pm

A medical oncologist provides a comprehensive overview of treatment options for patients with relapsed/refractory chronic lymphocytic leukemia, including BTK inhibitors and CAR T-cell therapy.